Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?
And here is our regular feature in which we highlight a different person each week. This time around, we note that Agios Pharmaceuticals hired Steve Hoerter as chief commercial officer. Previously he was executive vice president and chief commercial officer at Clovis Oncology, and, before that, he worked at Roche, Genentech, and Eli Lilly.
Astellas Pharma promoted James Robinson to president of its North and South America operations;
CancerLinQ hired Robert Merold as chief of strategic initiatives;
Patheon hired Andrew Long as senior vice president and global business controller;
Berg Pharma promoted Niven Narain to chief executive officer;
Berg Pharma hired Jason Haddock as chief financial officer and chief operating officer;
Amplyx Pharmaceuticals hired Dr. Michael Hodges as chief medical officer;
Amplyx Pharmaceuticals hired Karen Shaw as vice president of biology;
Amplyx Pharmaceuticals hired Elizabeth Gordon as vice president of regulatory affairs;
Xenon Pharmaceuticals hired James Empfield as senior vice president, drug discovery;
UroGen Pharma hired Dr. Mark Schoenberg as medical director;
Galmed Pharmaceuticals says Dr. Maya Halpern is retiring as chief medical officer;
Alder BioPharmaceuticals hired James Bucher as senior vice president and general counsel;
Alder BioPharmaceuticals hired Mary Tou as vice president of commercial strategy;
Alder BioPharmaceuticals hired Annette Vahratian as vice president of quality;
Alder BioPharmaceuticals hired David Walsey as vice president of corporate communications.
About the Author Reprints
